Wolfgang Gaebel

from Wikipedia, the free encyclopedia

Wolfgang Gaebel (born May 5, 1947 in Braunschweig ) is a German psychiatrist , university professor and former clinic director.

Wolfgang Gaebel
Wolfgang Gaebel (2017)

Life

Gaebel studied human medicine at the Free University of Berlin , received his doctorate in medicine there in 1972 and obtained his license to practice medicine in 1974. In 1980 he completed his specialist training in neurology and psychiatry at the Free University of Berlin; In 1989 he qualified as a professor in psychiatry, and in 1990 he received an additional qualification in psychotherapy .

In 1992 Gaebel was appointed full professor to the chair for psychiatry and psychotherapy at the Heinrich Heine University in Düsseldorf . In this position he was also director of the clinic and polyclinic for psychiatry and psychotherapy at the University Clinic in Düsseldorf and director of the LVR Clinic in Düsseldorf ; He was followed in 2016 by Eva Meisenzahl-Lechner .

Gaebel was previously chairman of the German Society for Biological Psychiatry and, a few years ago, of the German Society for Psychiatry, Psychotherapy and Neurology and, until May 2015, Vice-President of the AWMF ( Working Group of Scientific Medical Societies ). He is a member of the scientific advisory board of the German Medical Association and, since 2001, of the German Academy of Natural Scientists Leopoldina . In the World Association of Psychiatry ( WPA ) Gaebel is active in various functions, for example as chairman of the German antistigma association "Open the doors" or as chairman of the "Section on Schizophrenia". At the 2007 American Psychiatric Association's annual convention , Gaebel revealed his conflicts of interest ; he or she works as a consultant, receives or has received research / funding, or has stock (or other financial options) in AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly & Co., GlaxoSmithKline, H. Lundbeck A / S, Janssen-Cilag, Lilly, Lundbeck, Novartis Pharmaceuticals Corp., Sanofi-Aventis and Wyeth Pharmaceuticals. Gaebel is also co-founder and chairman of the Mental Health Action Alliance, a nationwide anti-stigma organization. Gaebel has been President of the European Psychiatric Association (EPA) since January 2015.

Sources and individual references

  1. ↑ Press release on the departure of Prof. Gaebel
  2. ^ American Psychiatric Association (May 19-24 , 2007), Program of the 160th Annual Meeting: Continuing medical education policy on full disclosure (p. XXIV), San Diego, California. Downloaded February 18, 2015.

Web links

personal data
SURNAME Gaebel, Wolfgang
BRIEF DESCRIPTION German psychiatrist, university professor and clinic director
DATE OF BIRTH May 5, 1947
PLACE OF BIRTH Braunschweig